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Abstract 
Objective: The aim of this work was to review de literature about the role of mesenchymal stem cells in bone rege-
nerative procedures in oral implantology, specifically, in the time require to promote bone regeneration.
Study Desing: A bibliographic search was carried out in PUBMED with a combination of different key words. 
Animal and human studies that assessed histomorphometrically the influence of mesenchymal stem cells on bone 
regeneration procedures in oral implantology surgeries were examined.
Reults:
- Alveolar regeneration: Different controlled histomorphometric animal studies showed that bone regeneration is 
faster using stem cells seeded in scaffolds than using scaffolds or platelet rich plasma alone. Human studies revea-
led that stem cells increase bone regeneration.
- Maxillary sinus lift: Controlled studies in animals and in humans showed higher bone regeneration applying stem 
cells compared with controls.
- Periimplantary bone regeneration and alveolar distraction: Studies in animals showed higher regeneration when 
stem cells are used. In humans, no evidence of applying mesenchymal stem cells in these regeneration procedures 
was found.
Conclusion: Stem cells may promote bone regeneration and be useful in bone regenerative procedures in oral im-
plantology, but no firm conclusions can be drawn from the rather limited clinical studies so far performed.
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Introduction
Embryonic stem cells are derived from blastocysts (1) 
and are considered as pluripotent cells as they are able 
to form all the body´s lineages (endoderm, mesoderm 
and ectoderm) (2). Mesenchymal stem cells (MSC) are 
one type of adult stem cells, that are able to give rise 
to tissues of mesodermal origin such as dentine, bone, 
or periodontal ligament (3). Bone regenerative potential 
of MSC has been evaluated in bone defects in animals 
(4-6). The histomorfometric results of these studies 
showed higher bone regeneration using MSC seeded on 
a scaffold that with the unseeded scaffold (4-6) and simi-
lar results than with autogenous bone grafts (6).
Surgical bone regeneration procedures such as guided 
bone regeneration or maxillary sinus augmentation, are 
well established (7), but methods that do not require the 
collection of autogenous bone, but that ensure sufficient 
bone formation in a short period of time are interesting 
(8). To achieve this goal several agents like bone morfo-
genertic proteins (9,10), platelet rich plasma (PRP) (11), 
melatonin (12) or stem cells (13) have been studied with 
different outcomes. Using tissue engineering, different 
recent studies have applied MSC in bone regeneration 
in oral implantology. MSC have been used in alveolar 
regeneration (14), maxillary sinus augmentation (15), 
periimplantary bone regeneration (16) or alveolar dis-
traction (17), in human and animal studies. Results of 
these histomorphometric animal studies (14,15) have 
shown that MSC enhance bone regeneration in a shorter 
period of time than biomaterials alone. Clinical human 
studies have also demonstrated higher bone regeneration 
when MSC have been applied (13,18).
The aim of this work was to review de literature about 
the role on MSC in bone regenerative procedures in oral 
implantology, specifically, in the time require to promote 
bone regeneration.
Material and Methods
A bibliographic search in PUBMED with a combination 
of different key words: mesenchymal stem cells, bone 
regeneration, dental implants, tissue engineering, dental 
pulp stem cells, periodontal ligament stem cells, apical 
papilla stem cells, deciduous teeth stem cells, oral im-
plantology, oral surgery. Moreover, the references of the 
articles were also assessed. English articles published 
until 2011 were evaluated. Animal and human studies 
that assessed the influence of MSC on bone regeneration 
procedures in oral implantology surgeries were exami-
ned. Studies about alveolar bone regeneration, maxillary 
sinus lift, periimplantary bone regeneration and alveolar 
distraction were identified.
- Inclusion criteria
Due to the number of studies performed no strict inclu-
sion criteria could be performed. Only studies that used 
MSC to performed bone regeneration where histologic 
or histomorfometric analysis was performed were in-
cluded. The studies should specify the moment where 
the analysis was carried out.
•  Clinical Human studies: Clinical trials, case-controls 
and case series were included. Case reports were ex-
cluded.
•  Animal studies: Controlled studies were included. 
Non-controlled studies were excluded.
When we applied these inclusion criteria, 26 articles 
were specifically analyzed. Table 1 shows the included 
articles.
Data about study design, bone regeneration surgery per-
formed and time of histologic -histomorfometric study 
was carefully taken in account. Different MSC sources, 
scaffolds and growth factors were used in the reviewed 
articles so no differences between studies could be per-
formed in this sense.
Mesenchymal stem cells in bone regeneration 
procedures applied to oral implantology
Tissue engineering is an emerging interdisciplinary field, 
which applies principles of life sciences and engineering 
towards the development of biological substitutes that 
restore, maintain and improve the function of damaged 
and/or lost tissues (19). In tissue engineering, scaffolds 
are required to give support to cells or other structures. 
Scaffolds are made of biodegradable material, which is a 
biocompatible product that is gradually reabsorbed once 
implanted in the body, usually due to enzymatic deg-
radation (20). The following sections review the most 
relevant animal and human studies, in which stem cells 
are used in the field of bone regeneration. All the stud-
ies mentioned apply the principles of tissue engineering 
stem cells. Thus scaffolds like xenografts (21), hydroxy-
apatite (23) or fibrin (22) are used. In different studies 
(6,16), PRP was used as a scaffold for the stem cells, 
but also as a graft material to evaluate its regeneration 
potential. 
- Alveolar bone regeneration
•  Animal studies
Different studies have compared bone regeneration using 
MSC and PRP. Yamada et al. (8) in 10 mm defects, 8 
weeks after grafting, showed that MSC and PRP were as 
effective as particulate autograft (67% and 61% of bone 
regenerated respectively); PRP alone caused a 29% of 
bone formation and 18% was found in non-regenerated 
cases. Using edentulous ridge in minipigs, Pieri et al. 
(23) observed higher bone formation with autogenous 
bone (47%) or MSC, PRP and fluorohydroxyapatite 
(45%) than with PRP and fluorohydroxyapatite (38%). 
Yoshimi et al. (24) observed similar effects using dogs. 
Moreover, Yamada et al. (25) evaluated the bone rege-
neration in mandibular defects with bone marrow MSC, 
dental pulp stem cells (DPSC), and stem cells from de-
ciduous teeth from their puppies; they observed bone 
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Type of 
Surgery
performed 
Type of 
study
Authors and 
year of publication
Histologic evaluation / percentage (%) of 
regenerated bone
Comments
Alveolar
bone
regeneration
Controlled 
studies
 in animals
Yamada et al. (6 ) 2004 MSC and PRP: 67%;  Autogenous: 61%;  PRP: 
29%
Not regenerated: 18%
10 mm defects. Significant differences between 
MSC/PRP,
 Autogenous and controls
Pieri et al. (23) 2009 MSC+PRP+fluorohydroxyapatite(FHA): 45%; 
Autogenous: 47%;  PRP + FHA: 38%; FHA: 
36%
3.5x8 mm defects. Similar effect grafting 
engineering bone 
and autograft. 
Yoshimi et al. (24) 
2009
PuraMatrix+MSC+PRP: 58% PuraMatrix+MSC: 
50%
PuraMatrix+PRP: 28% PuraMatrix: 25%
Not regenerated: 12% (8 weeks)
MSC groups showed a significant increase bone 
regenerated compared
 with the control, PuraMatrix®, or PuraMatrix 
+ PRP
Yamada et al. (25) 2011 Control: 19.0%; PRP: 19.7%; MSCs+PRP: 
52.8%
DPSC+PRP: 61.6%;
Puppy deciduous teeth MSCs+PRP: 54.7%
MSC from deciduous teeth may have the poten-
tial to generate
a graft between parent and child.
Mylonas et al. (14) 
2007
Control: 43% (4 weeks) 60% (7 weeks)
Study: 58% (4 weeks)   63% (7 weeks)
5mm three-wall defects. MSC accelerate the 
bone regeneration
 process
De kok et al. (26) 2005 HA/TCP+MSC: 34%; HA/TCP:25%;
Untreated sockets:35%
Neither implanted MSC-related inflammation 
nor ectopic osteogenesis was observed
Marei et al. (27) 2005 Histomorfometric evaluation 4 month after 
surgery
Regeneration and preservation of alveolar 
socket
Jafarian et al. (21) 2008 Kasios® + MSC: 65%;      Kasios®: 44%
Bio-Oss®+ MSC: 50%;     Bio-Oss®:36% (6 
weeks)     
10 mm jaw defects. Scaffolds have effect on 
bone regeneration with 
MSC
Abukawa et al. (28) 
2004
Unseeded scaffold: Bone formation limited to 
the periphery
Empty control: Thin bridge of bone
MSC scaffold: Bone completely bridge the 
defect
2x2 cm defects.
Case series
human study
Meijer et al. (29) 2008 Six patients. Four months after surgery, bone
 regeneration by MSC observed in one case
Bone marrow aspirate was taken, stem cells 
were cultured, expanded and grown for 7 days 
on a bone substitute
Prospective 
controlled 
human study
d´Aquino et al. (18) 
2009
Test sites: vascularized bone with lamellar ar-
chitecture, Control sites: immature, with fibrous 
bone.
DPSC in extraction shockets after impacted 
third molar removal
Maxillary
sinus lift
Controlled 
studies in 
animals
Pieri et al. (15) 2008 MSC, PRP and fluorohydroxyapatite: 42%
Fluorohydroxyapatite: 19% (12 weeks)
Split mouth study (16 maxillary sinus lifts in 8 
minipigs)
Sauerbier et al. (30) 
2010
Bone formation was significantly (p = 0.027) 
faster in the test sides
Histologic evaluation at 8 ad 16 weeks. MSC 
therapy could allow
early placement of implants.
Ohya et al. (31) 2005 MSC+PRP:29, 24 and 21 % (2, 4 and 8 weeks)
particulated autograft/PRP: 35, 28 and 21% (2, 4 
and 8 weeks)
Split mouth study in 18 adult japanese rabbits
Gutwald et al. (32) 
2010
MSC: 19% (8 weeks), 29% (16 weeks)
particulated autograft: 20% (8 weeks), 16% (16 
weeks)
MSC combined with bovine bone mineral have 
the potential to 
form bone
Case series
human study
Shayesteh et al. (33) 
2008
41% of regenerated bone (3 months) Less than 3 mm of residual bone. 6 patients.
Smiler et al. (34) 2007 MSC and xenograft or alloplastic graft Case repot of 5 patients. Bone marrow aspirated 
from iliac crest
McAlister et al.(8) 2009 MSC with allograft: 33% (4 months) Case repot of 5 patients. 
Prospective
Controlled 
human study
Gronshor et al. (35) 
2011
MSC+allograft: 32.5%; Allograft alone: 18.3% More rapid initiation of implant placement or 
restoration when
a cellular grafting approach is considered.
Prospective 
controlled 
clinical trial
Rickert  et al. (13) 2011 Bio-Oss® and MSC: 18% (15 weeks)
Bio-Oss® (70%) and Autograft (30%): 12% (15 
weeks)
Split month study in 12 patients.
Periimplantary
bone
regeneration
Controlled 
studies in 
animals
Yamada et al. (16) 2004 MSC and PRP: 79%; Autograft: 70%
PRP: 68%; Not regenerated: 63%
Artificially defects prior implant placement
Ito K et al. (22) 2006 Higher bone formation at 2, 4 and 8 weeks when 
MSC
were used
Best Bone-implant contact with 
MSC+PRP+fibrin 
(compared with controls)
Ito et al. (36) 2011 DPSC+PRP and bone marrow MSC+PRP: vital 
bone
Periosteal cells+PRP: Fibrous tissue
Engineered bone using DPSC showed higher 
bone-implant contact
than bone marrow MCS 
Kim et al. (37) 2009 Bone marrow MSC: 35%
periodontal ligament MSC: 32%
Periodontal ligament stem cells and bone mar-
row stem cells
Alveolar
distraction
Controlled 
studies in 
animals
Qi M et al. (38) 2006 MSC or physiological saline: significantly 
greater with MSC.
MSC alone accelerate bone regeneration com-
pared with controls
Kinoshita K et al. (39) 
2008
Significant new bone formation using MSC MSC with PRP accelerate bone regeneration 
compared with controls
Table 1. A summary of the results of the included articles about application of MSC for bone regeneration in implant dentistry.
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mm of residual bone. Three months later, histomorfo-
metric study showed 41% of regenerated bone. Thirty 
implants were placed in the grafted areas of which two 
failed. Other authors (34), performed maxillary sinus lift 
and onlay grafts using MSC mixed with xenograft or 
allograft in 5 patients. They observed bone regeneration 
in the grafted zones by histological and histomorfome-
tric analysis. McAlister et al. (8) performed direct sinus 
lifts to 5 patients using MSC with an allograft and they 
saw an average vital bone of 33% at 4 months. No im-
plant survival was recorded.
Gronshor et al. (35) in a controlled study, compared the 
regenerated bone grafting with allograft and MSC or 
allograft alone; they observed 3,7 month after, a 32.5% 
of vital bone in the cellular scaffold group compared 
with the 18.3% in the control.
Very recently the first controlled clinical trial using en-
gineered bone stem cells in maxillary sinus elevation 
has been performed. Rickert et al. (13) executed a split 
mouth study in 12 patients where they randomly graf-
ted one maxillary sinus with xenograft and bone marrow 
MSC, and the other with xenograft (70%) and autograft 
(30%). Fifteen weeks later, the histomorfometric study 
showed significantly higher bone formation in the MSC 
group (18%) than in the control (12%).
- Periimplantary bone regeneration
•  Animal studies
Animal studies have evaluated MSC combined with 
PRP in order to enhance periimplantary bone regenera-
tion. Yamada et al. (16) regenerated artificially created 
osseous dehiscence with MSC and PRP, PRP alone, 
autograft, or non- regenerated controls.  Two month la-
ter, implants were place in the grafted areas, and after 
another 2 month, a histometrically study was performed. 
Results showed that in those cases regenerated with 
MSC and PRP or with autografts, bone height remai-
ned constant. However, in those regenerated with PRP 
alone or not regenerated (controls), there was exposure 
of the implant threads. Ito et al. (22) performed a simi-
lar study in which implants were placed in bone with 
defects regenerated with the following graft materials: 
MSC with PRP and fibrin, MSC with fibrin, fibrin or non 
regenerated. The best periimplantary bone regeneration 
and highest bone-implant contact occurred when MSC 
with PRP and fibrin was used.
Different studies have evaluated the regeneration poten-
tial of stem cells harvested from different sources. Ito 
et al. (36) compared osseointegration of dental implants 
and tissue-engineered bone using DPSC, MSC from 
bone marrow or periosteal cells. Mandibular defects 
were filled with cells from one of these three sources and 
PRP. Eight weeks later, implants were placed, and after 
another 8 weeks, the percentage of bone-implant con-
tact was assessed. Results sowed 67%, 62% and 39 % of 
bone-implant contact for the DPSC, bone marrow MSC 
formation with the 3 groups compared with the controls 
(empty or PRP). They concluded that MSC from deci-
duous teeth may have the potential to generate a graft 
between parent and child.
Mylonas et al. (14) applied MSC to 5mm three-wall 
defects and performed histomorphometric analysis in 
two different moments. Four weeks after grafting, bone 
regeneration was higher in MSC group (58%) than in 
controls (43%). After 3 weeks more, histomorphome-
tric results were similar in both groups (63% and 60% 
respectively). These results showed that, although bone 
regeneration occurs when the necessary conditions were 
present, MSC accelerate the process.
Other studies exposed that MSC can also accelerate bone 
formation in alveolar shockets (26,27), in 10 mm jaw 
defects (21), or even in  greater defects (2x2 cm) (28). 
Clinical human studies• 
Meijer et al. (29) implanted MSC to regenerate alveolar 
bone defects in 6 patients. Four months later, bone rege-
neration was observed in 3 of them. The authors reported 
that only in one case, regeneration was performed more 
than 7 mm separated from the pre-existing bone walls, 
and for the authors, only in this case, regeneration was 
due to MSC. Of the 11 implants placed in 5 patients one 
failed. d´Aquino et al. (18) performed a clinical trial to 
assess the bone regeneration of DPSC in postextraction, 
impacted third molar sockets. They grafted one socket 
with DPSC in a collagen sponge scaffold and compared 
with non-grafted control. X-ray analyses and probing 
depth, showed better results in the study group. Three 
months after surgery, histologic analysis showed well 
vascularized bone with lamellar architecture in the stu-
dy sites, while control sites were immature, with fibrous 
bone.
- Maxillary sinus lift 
•  Animal studies
Controlled studies in animals using MSC to increase 
bone regeneration in maxillary sinus lifts have been per-
formed. Pieri et al. (15) in a split mouth study, perfor-
med 16 maxillary sinus lifts in 8 minipigs. MSC, PRP 
and fluorohydroxyapatite were placed in one side, and 
fluorohydroxyapatite alone in the other. Twelve weeks 
later, they observed 42% of regenerated bone when MSC 
were grafted and 19% in controls. Sauebier et al. (30) in 
a study in sheep showed that MSC accelerate bone rege-
neration compared with a xenograft alone. Other studies 
(31,32), observed 8 weeks after the intervention, similar 
bone regeneration whether grafting with MSC construct 
or with particulated autograft.
•  Clinical human studies
Clinical case series studies using MSC with different 
biomaterials have been performed. Shayesteh et al. (33) 
performed a clinical study in 6 patients, where MSC and 
beta-tricalcium phosphate/hydroxyapatite were used as 
graft material in maxillary sinus lifts with less than 3 
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5. Lee LT, Kwan PC, Chen YF, Wong YK. Comparison of the effec-
tiveness of autologous fibrin glue and macroporous biphasic calcium 
phosphate as carriers in the osteogenesis process with or without me-
senchymal stem cells. J Chin Med Assoc. 2008;71:66-73.
6. Yamada Y, Ueda M, Naiki T, Takahashi M, Hata K, Nagasaka T: 
Autogenous injectable bone for regeneration with mesenchymal stem 
cells and platelet-rich plasma: tissue-engineered bone regeneration. 
Tissue Eng. 2004;10:955-64.
7. Aghaloo TL, Moy PK. Which hard tissue augmentation techniques 
are the most successful in furnishing bony support for implant place-
ment? Int J Oral Maxillofac Implants. 2007;22 Suppl:49-70.
8. McAllister BS, Haghighat K, Gonshor A. Histologic evaluation 
of a stem cell-based sinus-augmentation procedure. J Periodontol. 
2009;80:679-86.
9. Boyne PJ, Lilly LC, Marx RE, Moy PK, Nevins M, Spagnoli DB 
y cols. De novo bone induction by recombinant human bone morpho-
genetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J 
Oral Maxillofac Surg. 2005;63:1693-707.
10. Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC 
y cols. A feasibility study evaluating rhBMP-2/absorbable collagen 
sponge for maxillary sinus floor augmentation. Int J Periodontics Res-
torative Dent. 1997;17:11-25.
11. Plachokova AS, Nikolidakis D, Mulder J, Jansen JA, Creugers NH. 
Effect of platelet-rich plasma on bone regeneration in dentistry: a sys-
tematic review. Clin Oral Implants Res. 2008;19:539-45.
12. Calvo-Guirado JL, Ramírez-Fernández MP, Gómez-Moreno G, 
Maté-Sánchez JE, Delgado-Ruiz R, Guardia J y cols. Melatonin sti-
mulates the growth of new bone around implants in the tibia of rabbits. 
J Pineal Res. 2010;49:356-63.
13. Rickert D, Sauerbier S, Nagursky H, Menne D, Vissink A, Rag-
hoebar GM. Maxillary sinus floor elevation with bovine bone mine-
ral combined with either autogenous bone or autogenous stem cells: 
a prospective randomized clinical trial. Clin Oral Implants Res. 
2011;22:251-8.
14. Mylonas D, Vidal MD, De Kok IJ, Moriarity JD, Cooper LF. Inves-
tigation of a thermoplastic polymeric carrier for bone tissue enginee-
ring using allogeneic mesenchymal stem cells in granular scaffolds. J 
Prosthodont. 2007;16:421-30.
15. Pieri F, Lucarelli E, Corinaldesi G, Iezzi G, Piattelli A, Giardino R 
y cols. Mesenchymal stem cells and platelet-rich plasma enhance bone 
formation in sinus grafting: a histomorphometric study in minipigs. J 
Clin Periodontol. 2008;35:539-46.
16. Yamada Y, Ueda M, Naiki T, Nagasaka T. Tissue-engineered injec-
table bone regeneration for osseointegrated dental implants. Clin Oral 
Implants Res. 2004;15:589-97.
17. Hibi H, Yamada Y, Kagami H, Ueda M. Distraction osteogenesis 
assisted by tissue engineering in an irradiated mandible: a case report. 
Int J Oral Maxillofac Implants. 2006;21:141-7.
18. d’Aquino R, De Rosa A, Lanza V, Tirino V, Laino L, Graziano A 
y cols. Human mandible bone defect repair by the grafting of dental 
pulp stem/progenitor cells and collagen sponge biocomplexes. Eur 
Cell Mater. 2009;18:75-83.
19. Langer R, Vacanti JP. Tissue engineering. Science. 
1993;260:920-6.
20. Fuchs JR, Hannouche D, Terada S, Zand S, Vacanti JP, Fauza DO. 
Cartilage engineering from ovine umbilical cord blood mesenchymal 
progenitor cells. Stem Cells. 2005;23:958-64.
21. Jafarian M, Eslaminejad MB, Khojasteh A, Mashhadi Abbas F, 
Dehghan MM, Hassanizadeh R y cols. Marrow-derived mesenchymal 
stem cells-directed bone regeneration in the dog mandible: a compa-
rison between biphasic calcium phosphate and natural bone mineral. 
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:14-24.
22. Ito K, Yamada Y, Naiki T, Ueda M. Simultaneous implant place-
ment and bone regeneration around dental implants using tissue-engi-
neered bone with fibrin glue, mesenchymal stem cells and platelet-rich 
plasma. Clin Oral Implants Res. 2006;17:579-86.
23. Pieri F, Lucarelli E, Corinaldesi G, Fini M, Aldini NN, Giardino 
R y cols. Effect of mesenchymal stem cells and platelet-rich plasma 
on the healing of standardized bone defects in the alveolar ridge: a 
comparative histomorphometric study in minipigs. J Oral Maxillofac 
Surg. 2009;67:265-72.
and periosteal cells respectively. In the stem cells groups 
vital bone was observed while in the periosteal cell and 
the empty control fibrous tissue was found. Kim et al. 
(37) observed higher periimplantary bone regeneration 
grafting the defects with bone marrow MSC than with 
periodontal ligament MSC (35 and 32% of regenerated 
bone respectively).
- Alveolar distraction
•  Animal studies
Qi et al. (38) evaluated the effect of MSC on bone forma-
tion in 40 male rats; after distraction was completed, the 
gap was filled with MSC or physiological saline. Callus 
formation was found in both treatment groups, but they 
observed, on days 27 and 55 after the onset of the dis-
traction, higher radiodensity and bone formation when 
MSC were used. Kinoshita et al. (39) studied the effect 
of MSC and PRP on bone formation in alveolar distrac-
tion in 12 rabbits. A radiologic and morphometric study 
was performed 2, 3 and 4 weeks post-distraction. Better 
results were obtained when the gap was infiltrated with 
MSC and PRP than when physiological saline or PRP 
alone were used.
Table 1 shows the results of the included studies.
Conclusions
Controlled animal studies reveal that stem cells com-
bined with PRP accelerate bone regeneration in oral 
implantology surgeries. This combination has shown 
higher capacity than PRP alone to promote bone regene-
ration. Controlled, long-term follow up clinical human 
studies have not been performed, but so far, no serious 
complications related to stem cells grafting (like syste-
mic inflammatory response) have been reported. There 
is only one very recently clinical trial performing maxi-
llary sinus lift using stem cells seeded on a xenograft 
showing similar morphometric results than autografts 
with xenograft. The interesting results of this clinical 
work as well as those of previous animal studies, indi-
cate that stem cells may promote bone regeneration and 
be useful in human oral implantology. Many different 
scaffolds are used; for this reason and the heterogeneity 
between studies, no big conclusions can be performed 
yet. More clinical controlled studies applying stem cells 
are necessary to validate in humans, the favorable re-
sults observed in animals.
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